Compare BIO & DCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | DCI |
|---|---|---|
| Founded | 1952 | 1915 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Pollution Control Equipment |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 10.7B |
| IPO Year | N/A | 1987 |
| Metric | BIO | DCI |
|---|---|---|
| Price | $300.28 | $92.33 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $358.50 | $92.50 |
| AVG Volume (30 Days) | 170.4K | ★ 903.8K |
| Earning Date | 10-29-2025 | 12-04-2025 |
| Dividend Yield | N/A | ★ 1.30% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.21 |
| Revenue | $2,557,500,000.00 | ★ $3,726,200,000.00 |
| Revenue This Year | $1.77 | $4.39 |
| Revenue Next Year | $2.30 | $4.49 |
| P/E Ratio | ★ N/A | $28.88 |
| Revenue Growth | N/A | ★ 2.37 |
| 52 Week Low | $211.43 | $57.45 |
| 52 Week High | $373.69 | $95.00 |
| Indicator | BIO | DCI |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 58.54 |
| Support Level | $298.02 | $90.13 |
| Resistance Level | $307.78 | $92.85 |
| Average True Range (ATR) | 8.35 | 1.99 |
| MACD | -2.13 | -0.15 |
| Stochastic Oscillator | 16.30 | 65.13 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.7 billion in revenue in its fiscal 2025.